Skip to main content

Table 2 Interviews with obstetric health care providers on the standard local care regarding HDP

From: Bottom-up development of national obstetric guidelines in middle-income country Suriname

Hypertensive disorders of pregnancy n = 43 (100%)
Definitions clear
 - Pre-eclampsia 38 (88)
 - Severe pre-eclampsia 22 (51)
 - Eclampsia 34 (79)
Anticipation / prevention
 - Risk factors known 36 (84)
 - Aspirine 10 (23)
 - Calcium 22 (51)
Oral medical treatment (1st line)
 1. Methyldopa 43 (100)
 2. Hydralazine 43 (100)
 3. Nifidipine (antepartum) 5 (12)
 4. Labetalol 21 (48)
Parenteral medical treatment (2nd line)
 1. Hydralazine (direct shots) 43 (100)
 2. Hydralazine (perfussor) 25 (58)
 3. Labetalol 15 (35)
 4. Ketanserin 5 (12)
Magnesium sulfate
 - Loading dose (4–6 g/30 min) 26 (60)
 - Maintanance dose (1 g/hr) 43 (100)
 - Initiation threshold: BP ≥110 32 (74)
 - Duration: 24 – 48 hours 43 (100)
 - Repeat (2 g/5 min) in seizure 6 (14)
 - Diazepam before MgSO4 38 (88)
Stabilization of severe PE / eclampsia
 - Minimum 48 hr before termination of pregnancy 8 (19)
Earliest termination in severe PE
 - GA ≥ 27 weeks 23 (53)
 - GA ≥ 30 weeks 15 (35)
 - GA ≥ 32 weeks 5 (12)
Other
 - Eclampsia box availablea 9 (21)
 - Oxygen during eclampsia 12 (28)
 - Two i.v. access lines 22 (51)
 - i.v. loading fluid before MgSO4 7 (16)
 - Restrict fluids to < 2 L / 24 hrs 0 (0)
 - Early warning score (MEOWS) 7 (16)
  1. aEclamspia kit includes magnesium sulfate, calciumgluconate, labetalol, hydralazin, sodium choloride ampoule, fluids (ringers lactate and sodium chloride), blood sample bottles, tourniquet, syringes, plaster to fix cannula, guedel aiways, bag and mask, oxygen, reflex hammer